ArticleBMC medicine2025

Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer.

Shao-Jing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.